126 related articles for article (PubMed ID: 12544891)
21. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
[TBL] [Abstract][Full Text] [Related]
22. The Incidence of Cytomegalovirus Glycoprotein B Genotypes in Kidney Transplant Recipients in Iran.
Soleimani AR; Jafari M; Piroozmand A; Nikoueinejad H; Akbari H; Einollahi B
Int J Organ Transplant Med; 2018; 9(4):173-177. PubMed ID: 30863520
[TBL] [Abstract][Full Text] [Related]
23. HLA antigen distribution in renal transplant recipients and donors.
Tuladhar A; Shrestha S; Raut PP; Bhandari P; Shrestha P
J Nepal Health Res Counc; 2013 Sep; 11(25):289-92. PubMed ID: 24908533
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies.
Giest S; Grace S; Senegaglia AC; Pasquini R; Gonzalo-Daganzo RM; Fernández MN; Mackinnon S; Madrigal JA; Travers PJ
Br J Haematol; 2010 Jan; 148(2):311-22. PubMed ID: 20095088
[TBL] [Abstract][Full Text] [Related]
25. Early increase of peripheral B cell levels in kidney transplant recipients with CMV infection or reactivation.
Besançon-Watelet C; De March AK; Renoult E; Kessler M; Béné MC; Faure GC; Sarda MN
Transplantation; 2000 Feb; 69(3):366-71. PubMed ID: 10706044
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.
Humar A; Kumar D; Gilbert C; Boivin G
J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447
[TBL] [Abstract][Full Text] [Related]
27. Association between antibody response against cytomegalovirus strain-specific glycoprotein H epitopes and HLA-DR.
Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Shishido K; Aikawa K; Yamaguchi O; Toma H; Tanabe K; Suzutani T
Microbiol Immunol; 2009 Jul; 53(7):412-6. PubMed ID: 19563400
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and genotype distribution of cytomegalovirus UL55 sequence in renal transplant recipients in north west of Iran.
Khalafkhany D; Makhdoomi K; Taghizadeh Afshari A; Motazakker M
J Med Virol; 2016 Sep; 88(9):1622-7. PubMed ID: 26946241
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype.
Aquino VH; Figueiredo LT
J Med Virol; 2000 May; 61(1):138-42. PubMed ID: 10745246
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles.
Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC
J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus and HLA-A, B, and DR locus interactions: impact on renal transplant graft survival.
Schnitzler MA; Woodward RS; Brennan DC; Phelan DL; Spitznagel EL; Boxerman SB; Dunagan WC; Bailey TC
Am J Kidney Dis; 1997 Dec; 30(6):766-71. PubMed ID: 9398119
[TBL] [Abstract][Full Text] [Related]
32. Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation.
Guberina H; Tomoya Michita R; Dolff S; Bienholz A; Trilling M; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113092
[TBL] [Abstract][Full Text] [Related]
33. Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.
Rovito R; Claas FHJ; Haasnoot GW; Roelen DL; Kroes ACM; Vossen ACTM
J Reprod Immunol; 2018 Apr; 126():39-45. PubMed ID: 29477013
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
[TBL] [Abstract][Full Text] [Related]
35. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.
Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P
Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095
[TBL] [Abstract][Full Text] [Related]
36. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?
Wong G; Chakera A; Chapman JR; Chadban SC; Pilmore H; Craig JC; Lim WH
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860123
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China.
Wu X; Wang Y; Xu Y; Wu D; Sun A; Zhu Z; Han Y; Qiu H; Tang X; Fu Z; He G; Li C; Ma X; Liu Y
Biol Blood Marrow Transplant; 2010 May; 16(5):647-52. PubMed ID: 20025986
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
[TBL] [Abstract][Full Text] [Related]
40. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation.
Torok-Storb B; Boeckh M; Hoy C; Leisenring W; Myerson D; Gooley T
Blood; 1997 Sep; 90(5):2097-102. PubMed ID: 9292549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
